These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 28231275)

  • 1. Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro.
    Stahnke T; Kowtharapu BS; Stachs O; Schmitz KP; Wurm J; Wree A; Guthoff RF; Hovakimyan M
    PLoS One; 2017; 12(2):e0172592. PubMed ID: 28231275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Pirfenidone on TGF-β1-Induced Myofibroblast Differentiation and Extracellular Matrix Homeostasis of Human Orbital Fibroblasts in Graves' Ophthalmopathy.
    Wu SB; Hou TY; Kau HC; Tsai CC
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts.
    Conte E; Gili E; Fagone E; Fruciano M; Iemmolo M; Vancheri C
    Eur J Pharm Sci; 2014 Jul; 58():13-9. PubMed ID: 24613900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1.
    Jin J; Togo S; Kadoya K; Tulafu M; Namba Y; Iwai M; Watanabe J; Nagahama K; Okabe T; Hidayat M; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Sasaki S; Tominaga S; Takahashi K
    Respir Res; 2019 Jun; 20(1):119. PubMed ID: 31185973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway.
    Sun YW; Zhang YY; Ke XJ; Wu XJ; Chen ZF; Chi P
    Eur J Pharmacol; 2018 Mar; 822():199-206. PubMed ID: 29374548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19.
    Choi K; Lee K; Ryu SW; Im M; Kook KH; Choi C
    Mol Vis; 2012; 18():1010-20. PubMed ID: 22550395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
    Epstein Shochet G; Wollin L; Shitrit D
    Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model.
    Li G; Ren J; Hu Q; Deng Y; Chen G; Guo K; Li R; Li Y; Wu L; Wang G; Gu G; Li J
    Biochem Pharmacol; 2016 Oct; 117():57-67. PubMed ID: 27498142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different fibroblast subpopulations of the eye: a therapeutic target to prevent postoperative fibrosis in glaucoma therapy.
    Stahnke T; Löbler M; Kastner C; Stachs O; Wree A; Sternberg K; Schmitz KP; Guthoff R
    Exp Eye Res; 2012 Jul; 100():88-97. PubMed ID: 22579993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon's fibroblasts in vitro.
    Lin X; Yu M; Wu K; Yuan H; Zhong H
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3763-70. PubMed ID: 19264889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirfenidone inhibits transforming growth factor β1-induced extracellular matrix production in nasal polyp-derived fibroblasts.
    Shin JM; Park JH; Park IH; Lee HM
    Am J Rhinol Allergy; 2015; 29(6):408-13. PubMed ID: 26637578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis.
    Rønnow SR; Dabbagh RQ; Genovese F; Nanthakumar CB; Barrett VJ; Good RB; Brockbank S; Cruwys S; Jessen H; Sorensen GL; Karsdal MA; Leeming DJ; Sand JMB
    Respir Res; 2020 May; 21(1):108. PubMed ID: 32381012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pirfenidone Inhibits Cell Proliferation and Collagen I Production of Primary Human Intestinal Fibroblasts.
    Cui Y; Zhang M; Leng C; Blokzijl T; Jansen BH; Dijkstra G; Faber KN
    Cells; 2020 Mar; 9(3):. PubMed ID: 32235767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
    Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
    BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific Features of Fibrotic Lung Fibroblasts Highly Sensitive to Fibrotic Processes Mediated via TGF-β-ERK5 Interaction.
    Kadoya K; Togo S; Tulafu M; Namba Y; Iwai M; Watanabe J; Okabe T; Jin J; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Takeda T; Kondo N; Takahashi K
    Cell Physiol Biochem; 2019; 52(4):822-837. PubMed ID: 30946557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors.
    Didiasova M; Singh R; Wilhelm J; Kwapiszewska G; Wujak L; Zakrzewicz D; Schaefer L; Markart P; Seeger W; Lauth M; Wygrecka M
    FASEB J; 2017 May; 31(5):1916-1928. PubMed ID: 28148565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells.
    Hisatomi K; Mukae H; Sakamoto N; Ishimatsu Y; Kakugawa T; Hara S; Fujita H; Nakamichi S; Oku H; Urata Y; Kubota H; Nagata K; Kohno S
    BMC Pulm Med; 2012 Jun; 12():24. PubMed ID: 22694981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells.
    Molina-Molina M; Machahua-Huamani C; Vicens-Zygmunt V; Llatjós R; Escobar I; Sala-Llinas E; Luburich-Hernaiz P; Dorca J; Montes-Worboys A
    BMC Pulm Med; 2018 Apr; 18(1):63. PubMed ID: 29703175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The
    Tao Y; Chen Q; Zhao C; Yang X; Cun Q; Yang W; Zhang Y; Zhu Y; Zhong H
    Int J Med Sci; 2020; 17(6):734-744. PubMed ID: 32218695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.